Turk J Hematol. 2022; 39(4): 275-276 | DOI: 10.4274/tjh.galenos.2022.2022.0397

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia

Abdulkadir Erçalışkan¹, Fatma Zehra Avcı², Ahmet Emre Eşkazan^3
1Düzce Atatürk State Hospital, Department of Internal Medicine, Division of Hematology, Düzce, Turkey
²İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, İstanbul, Turkey
³İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

Keywords: Eltrombopag, Ibrutinib, Thrombocytopenia, Toxicity, Waldenström macroglobulinemia

---

Waldenström Makroglobulinemisi Olan Bir Hastada İbrutinib ile İlişkili Trombositopeninin Eltrombopag ile Başarılı Yönetimi

Abdulkadir Erçalışkan¹, Fatma Zehra Avcı², Ahmet Emre Eşkazan^3
1Düzce Atatürk State Hospital, Department of Internal Medicine, Division of Hematology, Düzce, Turkey
²İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, İstanbul, Turkey
³İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

Anahtar Kelimeler: Eltrombopag, İbrutinib, Trombositopeni, Toksisite, Waldenström makroglobulinemisi

---

CITE